Actuate Therapeutics, Inc.
ACTU
$1.95
$0.021.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.54M | -22.23M | -24.12M | -24.68M | -25.31M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.44M | 6.07M | 5.72M | 5.14M | 4.79M |
| Change in Net Operating Assets | -4.50M | -3.05M | -1.84M | -3.17M | -694.60K |
| Cash from Operations | -19.60M | -19.21M | -20.24M | -22.71M | -21.21M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 0.00 | 200.00K | 1.20M |
| Total Debt Repaid | -- | -- | 0.00 | -200.00K | -200.00K |
| Issuance of Common Stock | 24.55M | 24.03M | 24.03M | 31.16M | 23.96M |
| Repurchase of Common Stock | -527.70K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -169.30K | -302.80K | -382.90K | -2.31M | -1.92M |
| Cash from Financing | 23.85M | 23.72M | 23.64M | 28.85M | 23.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.24M | 4.52M | 3.40M | 6.14M | 1.82M |